SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-032941
Filing Date
2020-12-07
Accepted
2020-12-07 21:50:44
Documents
1
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 17240
  Complete submission text file 0000899243-20-032941.txt   18603
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301
Business Address
Harding Thomas C. (Reporting) CIK: 0001834833 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35347 | Film No.: 201374276